Cancer Screening Tests by Age: What Evidence-Based Guidelines Recommend

The postcard shows up a few weeks after your 45th birthday, tucked between a utility bill and a pizza coupon: it’s time to schedule colorectal cancer screening. For a lot of people, that little card is the first real signal that the calendar itself has become a medical instrument — that certain birthdays now come with homework.

Which birthdays, exactly? That’s where things get murky. Friends swear their doctor started mammograms at 40; a cousin says 45. Someone at work paid out of pocket for a blood test that claims to look for dozens of cancers at once. Ads promise early detection the way they once promised whiter teeth.

Underneath the noise sits a surprisingly orderly set of recommendations, built on decades of trial data and updated as evidence shifts. Here is what the major guidelines actually say, age by age — including the honest limits nobody puts in an ad.

What are the most common cancer screening tests?

Four cancers have screening tests backed by strong evidence that finding disease early saves lives: breast, cervical, colorectal, and — for people with a heavy smoking history — lung. A fifth, prostate, sits in a gray zone where screening is offered as an individual choice rather than a blanket recommendation.

The workhorses look like this. Mammography uses low-dose X-rays to spot breast tumors too small to feel. Cervical screening uses either a Pap test, which examines cells for precancerous changes, or an HPV test, which detects the virus responsible for more than nine in ten cervical cancers. Colorectal screening comes in several forms, from colonoscopy — which can remove precancerous polyps on the spot — to stool tests you complete at home. Lung screening uses a low-dose CT scan, a quick imaging study delivering a fraction of a standard CT’s radiation.

Notice what’s not on the list. There is no routine blood panel that screens for cancer in general, no whole-body scan recommended for healthy adults, and no evidence-supported skin cancer screening program for people at average risk — the U.S. Preventive Services Task Force has repeatedly found the data insufficient to recommend routine full-body skin exams for the general population, though checking your own skin and reporting changing moles remains sensible.

Everything that follows unpacks when each test starts, how often it repeats, and why the ages were chosen. The short version: the schedule follows the biology of each cancer, not a bureaucrat’s whim.

Your 20s and 30s: cervical screening starts the clock

Cancer screening begins earlier than most people expect — at 21, with the cervix. The reasoning is straightforward: cervical cancer develops slowly, over ten to twenty years, from precancerous cell changes caused almost entirely by persistent human papillomavirus (HPV) infection. Catch the precancer, treat it, and the cancer never happens. That’s why cervical screening is one of the few tests that genuinely prevents cancer rather than just detecting it.

The schedule for people with a cervix runs in two phases:

• Ages 21 to 29: a Pap test every three years. HPV infections are so common and so frequently cleared by the immune system in this age group that testing for the virus itself would flag many infections destined to resolve on their own.
• Ages 30 to 65: the preferred option in many guidelines is a primary HPV test every five years. Alternatives include a Pap test every three years or a combined HPV-plus-Pap test every five.

Beyond the cervix, your 20s and 30s are mostly screening-quiet — unless your family history says otherwise. A parent or sibling diagnosed with colorectal cancer at 50, for example, moves your first colonoscopy up to age 40, or ten years before their diagnosis age, whichever comes first. These decades are also when knowing your family’s cancer history, in specific detail, pays the biggest dividends. Ask the awkward questions at the next holiday gathering; write the answers down.

Age 40: when mammograms enter the picture

Forty is the new starting line for breast cancer screening. In 2024, the U.S. Preventive Services Task Force updated its recommendation: women and people assigned female at birth at average risk should get a mammogram every two years from age 40 through 74. Previously, the recommendation had emphasized age 50; the change reflects rising breast cancer rates among women in their 40s and modeling showing that starting earlier prevents more deaths, particularly among Black women, who die of breast cancer at roughly 40 percent higher rates than white women.

Other respected bodies read the evidence slightly differently — some support annual screening, and many clinicians offer yearly mammograms from 40 or 45. The disagreement isn’t about whether mammography works; pooled trial data suggest it reduces breast cancer deaths by roughly 20 percent among those screened. The debate is about trade-offs: more frequent screening finds some cancers earlier but also generates more false alarms and biopsies.

Two practical notes matter here. First, if you have dense breast tissue — now reported on every U.S. mammogram result by federal rule — the mammogram is harder to read, and your clinician may discuss supplemental imaging. Second, a significant family history of breast or ovarian cancer, or a known BRCA1 or BRCA2 gene variant in the family, can change everything: earlier starts, MRI added to mammography, and referral for genetic counseling. Average-risk schedules are exactly that — for average risk.

Age 45: colorectal screening — and why it moved earlier

For decades, colorectal screening began at 50. In 2021, the starting age dropped to 45 — a direct response to a troubling trend: colorectal cancer rates in adults under 50 have been climbing since the 1990s, for reasons researchers are still working to untangle. People born around 1990 face roughly double the colon cancer risk of people born around 1950 at the same age.

The stakes justify the paperwork. When colorectal cancer is caught while still localized, five-year relative survival exceeds 90 percent; once it has spread to distant organs, that figure falls below 20 percent. Better yet, colonoscopy can remove precancerous polyps during the exam itself — screening and prevention in a single appointment.

Guidelines endorse several options for average-risk adults from 45 to 75:

• Colonoscopy every 10 years — the most thorough option, requiring bowel prep and usually sedation
• Stool FIT test every year — an at-home kit checking for hidden blood
• Stool DNA-FIT test every one to three years — checks for blood plus altered DNA shed by tumors
• CT colonography or flexible sigmoidoscopy every five years

Here’s the honest catch with the convenient options: a positive stool test isn’t a diagnosis — it’s a ticket to a follow-up colonoscopy, and skipping that follow-up erases the benefit. Studies have found a meaningful share of people with positive stool tests never complete the colonoscopy. The best test, as gastroenterologists like to say, is the one you actually finish.

Ages 50 to 80: lung cancer screening for people who smoked

Lung cancer kills more Americans than breast, colorectal, and prostate cancers combined, largely because it’s usually found late. Screening exists — but only for a defined group, because that’s where the evidence shows benefit outweighing harm.

Current guidelines recommend a yearly low-dose CT scan for adults who meet all three criteria:

• Age 50 to 80
• A smoking history of at least 20 pack-years (a pack-year equals one pack a day for a year — so a pack a day for 20 years, or two packs a day for 10)
• Currently smoke, or quit within the past 15 years

The recommendation rests on serious evidence. The National Lung Screening Trial, which enrolled more than 53,000 participants, found that low-dose CT reduced lung cancer deaths by about 20 percent compared with chest X-rays. The scan itself is quick — a few minutes, no needles, no dyes, and a radiation dose far below a conventional CT.

The trade-off worth knowing in advance: lung nodules are common, and most are harmless scars or inflammation. A substantial share of people screened will have a finding that requires follow-up imaging, and only a small fraction of those findings turn out to be cancer. Going in with that expectation makes a callback far less frightening.

One more thing clinicians emphasize, and the data back them up: screening never substitutes for quitting. Stopping smoking at any age lowers lung cancer risk more than any scan can, and the benefit begins within the first year.

Should men get a PSA test? It depends — and that's not a dodge

Prostate cancer screening is the guideline world’s most carefully hedged recommendation, and the hedging is honest, not evasive. The PSA test measures prostate-specific antigen, a protein in the blood that rises with prostate cancer — but also with benign prostate enlargement, inflammation, recent exercise, and simple aging.

The core dilemma: prostate cancer is common but often indolent. Many prostate cancers grow so slowly that a man is far more likely to die with the disease than from it. Screening finds both the dangerous cancers and the harmless ones, and the tests can’t always tell them apart at diagnosis. Historically, that led to treatment of cancers that never needed treating, with real consequences for urinary and sexual function.

So the U.S. Preventive Services Task Force recommends that men ages 55 to 69 make an individual decision after discussing benefits and harms with a clinician, and recommends against routine PSA screening at 70 and older. Some organizations suggest starting that conversation earlier — around 40 to 45 — for men at higher risk, including Black men, who face roughly double the prostate cancer death rate of white men, and anyone with a father or brother diagnosed with the disease.

Modern practice has softened the old harms considerably. Active surveillance — monitoring low-risk cancers rather than treating immediately — is now standard for many diagnoses. But the fundamental advice stands: PSA screening should be a decision you make with information, not a box checked without your knowledge on a lab slip.

Pap test vs. HPV test: what's the difference?

The two cervical screening tests get confused constantly, partly because the sample collection feels identical from the patient’s side — a speculum exam and a small brush of cells from the cervix, over in minutes. What happens in the lab is where they diverge.

A Pap test (or Pap smear) examines those cells under a microscope, looking for abnormal changes that could, over years, progress to cancer. It’s checking for damage already visible. An HPV test analyzes the same sample for the genetic material of high-risk human papillomavirus types — it’s checking for the cause before damage appears. Because nearly all cervical cancers stem from persistent high-risk HPV infection, a negative HPV test offers strong, durable reassurance, which is why it can be safely repeated every five years instead of every three.

A few points people frequently get wrong:

• A positive HPV test is not a cancer diagnosis — most infections clear on their own; a positive result means closer monitoring, not panic.
• People who received the HPV vaccine still need cervical screening; the vaccine covers the most dangerous virus types but not all of them.
• Screening can usually stop after 65 for those with a solid record of recent normal results — but not before confirming that record with a clinician.
• Anyone with a cervix needs screening, including many transgender men and nonbinary people, a group with documented gaps in screening rates.

In several countries, self-collected HPV samples are becoming an option, and U.S. availability is expanding — a development worth asking about if pelvic exams are a barrier.

Is there a test that can check for all cancers?

This is the question behind those blood-test ads, so it deserves a direct answer: no. There is currently no test — blood, imaging, or otherwise — that reliably screens for all cancers, and no multi-cancer detection test is recommended by the U.S. Preventive Services Task Force or any major evidence-based guideline body.

The technology itself is genuinely interesting. Multi-cancer early detection (MCED) tests analyze blood for fragments of DNA and other molecules shed by tumors, aiming to flag dozens of cancer types — including many, like pancreatic and ovarian cancer, that have no standard screening test at all. The National Cancer Institute is running large studies to find out whether these tests actually reduce cancer deaths.

That last phrase is the crux. Detecting cancer earlier is not automatically the same as helping people live longer — a counterintuitive truth explained by two statistical traps called lead-time bias and overdiagnosis. A test can find cancer months earlier without changing the outcome, making survival statistics look better while changing nothing real. Only randomized trials that track deaths can settle the question, and those results are years away.

Meanwhile, the practical caveats are significant. Sensitivity for early-stage cancers — the ones you most want to catch — is considerably lower than for advanced disease. A positive result triggers a search for the tumor, which may involve scans, biopsies, anxiety, and cost, and sometimes no cancer is ever found. And a negative result must never become a reason to skip the proven screening tests above. If you’re considering one, treat it as an add-on under discussion with your clinician — never a replacement.

Cancer screening tests by age: the schedule at a glance

Every schedule below applies to adults at average risk. Family history, genetic variants, prior abnormal results, and certain medical conditions can move starting ages earlier and shorten intervals — a topic covered later in this article. Intervals reflect current U.S. Preventive Services Task Force recommendations; some professional societies differ modestly on frequency.

Age range	Screening test	Typical interval
21–29	Cervical: Pap test	Every 3 years
30–65	Cervical: HPV test (preferred) or Pap	HPV every 5 years, or Pap every 3
40–74	Breast: mammogram	Every 2 years (some groups support yearly)
45–75	Colorectal: colonoscopy, stool test, or other options	Colonoscopy every 10 years; stool tests every 1–3 years
50–80	Lung: low-dose CT — only with a 20 pack-year smoking history, current or quit within 15 years	Every year
55–69	Prostate: PSA blood test, individualized decision	Set with a clinician after discussion

Two patterns are worth noticing in the table. First, screening has an end as well as a beginning: most recommendations taper off in the mid-70s to age 80, because for cancers that grow slowly, screening someone with a limited life expectancy exposes them to the harms of testing without time to realize the benefits. Second, no single decade is screening-free from 21 onward — which is a strong argument for keeping one clinician who knows your whole history and can keep the calendar for you.

Screening tests vs. diagnostic tests: why the difference matters

A mammogram ordered because it’s been two years and a mammogram ordered because you felt a lump are, medically speaking, different events — even if the machine is the same. The first is a screening test: performed on people with no symptoms, to catch disease before it announces itself. The second is a diagnostic test: performed to investigate a specific finding or complaint.

The distinction has practical teeth. Under the Affordable Care Act, most U.S. insurance plans must cover guideline-recommended screening tests without cost-sharing — no copay, no deductible. Diagnostic tests follow ordinary coverage rules, which can mean real bills. This occasionally produces a frustrating scenario: a screening colonoscopy finds a polyp, the polyp is removed, and the procedure gets recoded. Federal guidance has clarified that polyp removal during a screening colonoscopy should still be covered as screening for most plans, but billing errors happen — worth contesting if one lands in your mailbox.

The distinction also explains why screening results come with follow-up rather than final answers. Screening tests are deliberately tuned to cast a wide net: better to flag ten suspicious shadows and clear nine with additional imaging than to miss the one that matters. A callback after a mammogram, a positive stool test, a flagged lung nodule — each is an invitation to a diagnostic workup, not a verdict. Roughly one in ten women is called back after a screening mammogram in the U.S.; the large majority of those callbacks end with normal findings. Knowing the system’s design keeps a recall letter in perspective.

The honest downsides: false positives, overdiagnosis, and false reassurance

Screening saves lives — the evidence for the tests in this article is real and hard-won. It also carries costs beyond money, and pretending otherwise does readers no favors.

False positives are the most common harm. Over ten years of annual mammograms, more than half of women will experience at least one false alarm requiring extra imaging, and a smaller share will undergo a biopsy that finds no cancer. The anxiety is not trivial; studies show it can linger for months.

Overdiagnosis is subtler and stranger: the detection of real cancers that would never have caused symptoms or death — tumors so slow-growing that something else would have ended the person’s life first. Because no one can be certain which cancers those are at diagnosis, overdiagnosed cancers usually get treated, with all the attendant side effects. Prostate cancer is the classic example; a portion of screen-detected breast cancers likely fall into this category too, with published estimates varying widely.

False negatives cut the other way. No screening test catches everything — mammography misses roughly one in eight breast cancers, more in dense tissue. A normal screening result is reassurance, not immunity, which is why new symptoms always warrant evaluation regardless of a recent clean test.

None of this argues against screening within guideline ages — the recommendations already weigh these harms against the benefits, and the math favors screening for the tests described here. It argues for going in with clear eyes: expect occasional callbacks, ask questions about findings, and never let a normal result silence a symptom.

What are the 7 warning signs of cancer?

The “seven warning signs” people search for come from an old public-health mnemonic, CAUTION, and it still holds up as a memory aid:

• Change in bowel or bladder habits that persists
• A sore that does not heal
• Unusual bleeding or discharge — including blood in stool or urine, or vaginal bleeding after menopause
• Thickening or a lump in the breast, testicle, or elsewhere
• Indigestion or difficulty swallowing that doesn’t resolve
• Obvious change in a wart or mole — size, shape, color, or bleeding
• Nagging cough or hoarseness lasting more than a few weeks

To that classic list, modern sources add unexplained weight loss (often defined as losing more than about 5 percent of body weight over six to twelve months without trying), persistent unexplained fatigue, night sweats, and pain that doesn’t go away.

Two pieces of context keep this list useful rather than frightening. First, every symptom above is far more often caused by something benign — infections, hemorrhoids, reflux, thyroid issues — than by cancer. The signal isn’t the symptom itself; it’s persistence without explanation. Second, and this is the point ads for miracle tests conveniently skip: symptoms are a late alarm. The entire logic of screening is to find cancer before any of these appear, which is why a clean bill of symptomatic health is never a reason to skip the schedule in the table above.

When to see a doctor

Make an appointment promptly — within days to a couple of weeks, not months — if you notice any of the following:

• Blood where it shouldn’t be: in stool, urine, or phlegm, or vaginal bleeding after menopause or between periods
• A new lump anywhere, or a change in an existing one
• Any symptom from the warning-signs list that persists beyond two to four weeks without a clear explanation
• Unintentional weight loss of roughly ten pounds or more
• A mole that is changing, asymmetric, multi-colored, larger than a pencil eraser, or bleeding
• Difficulty swallowing that is worsening, or food feeling stuck

Seek urgent or emergency care for severe symptoms: significant bleeding, sudden severe pain, difficulty breathing, or inability to keep food or fluids down.

The quieter reason to see a doctor is the one this whole article points toward: to build your screening plan. Bring your family cancer history — who was diagnosed with what, and at what age, on both sides — plus your smoking history in pack-years and any prior abnormal results. Ten minutes of that conversation produces a personalized calendar worth more than any online quiz.

A note on hesitation, because it’s human: studies consistently find that people delay reporting symptoms out of fear of what they’ll learn, or embarrassment about the body part involved. Clinicians have heard everything, examined everything, and would far rather investigate ten benign complaints than meet one cancer late. The earlier conversation is, in nearly every scenario the evidence describes, the easier one.

Family history and higher risk: when the standard schedule isn't enough

Everything above describes average risk — and a meaningful minority of readers aren’t average. Somewhere between 5 and 10 percent of cancers are linked to inherited gene variants, and a larger group has family patterns that shift the math without a known gene involved.

Common triggers for an earlier or intensified schedule include:

• Colorectal cancer in a first-degree relative (parent, sibling, child): colonoscopy typically starts at 40, or ten years before the relative’s diagnosis age — whichever is earlier — often repeating every five years instead of ten.
• Breast or ovarian cancer clustering in the family, especially diagnoses before 50, male breast cancer, or Ashkenazi Jewish ancestry: possible referral for genetic counseling and BRCA testing; carriers of high-risk variants may begin annual MRI plus mammography as early as their late 20s to 30.
• Lynch syndrome, an inherited condition raising colorectal, endometrial, and other cancer risks: colonoscopy can begin in the 20s, repeating every one to two years.
• Inflammatory bowel disease affecting the colon for eight or more years: earlier and more frequent colonoscopy.
• Prior chest radiation (for example, for childhood lymphoma): earlier breast screening, often with MRI.

Genetic counseling deserves a special word, because people often fear it means automatic testing or uninsurability. It doesn’t — a counselor maps your family history, estimates whether testing would change your care, and explains the federal Genetic Information Nondiscrimination Act protections before anything is drawn. If your family tree has cancer diagnoses before age 50, or the same cancer appearing across generations, that conversation belongs on your list.

Frequently asked questions

Is there a test that can check for all cancers?

No. No blood test, scan, or panel currently screens reliably for all cancers, and no multi-cancer early detection test is recommended by major evidence-based guideline bodies. Blood tests that look for tumor DNA fragments across many cancer types are in large clinical trials, but researchers don’t yet know whether they reduce cancer deaths. If you use one, it should supplement — never replace — proven screening like mammograms, colonoscopy, and cervical testing.

What are the 7 warning signs of cancer?

The classic CAUTION mnemonic lists: change in bowel or bladder habits; a sore that doesn’t heal; unusual bleeding or discharge; thickening or a lump; indigestion or trouble swallowing; obvious change in a wart or mole; and a nagging cough or hoarseness. Each is far more often caused by something benign — the meaningful signal is persistence beyond two to four weeks without explanation, which warrants a medical visit.

What are three common cancer screening tests?

The three most widely used are the mammogram for breast cancer, colonoscopy (or an at-home stool test) for colorectal cancer, and the Pap or HPV test for cervical cancer. All three are backed by decades of evidence and are typically covered without cost-sharing by most U.S. insurance plans when done on the recommended schedule. A fourth, low-dose CT lung screening, applies to people with a significant smoking history.

At what age should I get my first mammogram?

Age 40, for people at average risk, according to the U.S. Preventive Services Task Force’s 2024 recommendation, repeating every two years through 74. Some professional societies support annual screening, and many clinicians offer it. If you have a strong family history of breast or ovarian cancer, or a known BRCA gene variant in the family, screening may start earlier and include MRI — discuss your specific risk with a clinician.

Is an at-home stool test as good as a colonoscopy?

Both are guideline-endorsed, but they work differently. Colonoscopy examines the whole colon and removes precancerous polyps on the spot, and a normal result lasts ten years. Stool tests detect hidden blood or tumor DNA, must repeat every one to three years, and any positive result requires a follow-up colonoscopy. Evidence supports either path — the critical factors are completing the test on schedule and never skipping the follow-up after a positive result.

How often do I need a Pap smear or HPV test?

From ages 21 to 29, a Pap test every three years. From 30 to 65, guidelines prefer an HPV test every five years, with a Pap every three years or a combined test every five as alternatives. Screening can usually stop after 65 if recent results have been consistently normal. People who received the HPV vaccine still need screening, and anyone with a cervix — including many transgender men — should follow this schedule.

Does a normal screening result mean I definitely don't have cancer?

No — it means no cancer was detected, which is strong but not absolute reassurance. Every screening test misses some cancers; mammography, for instance, misses roughly one in eight breast cancers, more often in dense tissue. That’s why new or persistent symptoms — a lump, unexplained bleeding, lasting changes in bowel habits — always deserve medical evaluation, even shortly after a normal screening result.

Who qualifies for lung cancer screening?

Adults ages 50 to 80 who have at least a 20 pack-year smoking history (a pack a day for 20 years, or the equivalent) and who currently smoke or quit within the past 15 years. Screening is a yearly low-dose CT scan, which reduced lung cancer deaths by about 20 percent in a major trial of over 53,000 people. Adults without a significant smoking history are not candidates under current guidelines.

How does family history change my cancer screening schedule?

Substantially, in some cases. A parent or sibling with colorectal cancer typically moves your first colonoscopy to age 40 — or ten years before their diagnosis age — with repeats every five years. Breast or ovarian cancer clustering in the family, especially before age 50, may prompt genetic counseling and earlier screening with MRI. Bring specific details — who, which cancer, what age — to your next appointment so your schedule can be personalized.

Can a routine blood test detect cancer?

Generally no. Standard blood panels — complete blood counts, metabolic panels — are not cancer screening tests, though occasionally an abnormality prompts further investigation. The PSA test is one blood test used for screening, specifically for prostate cancer, and it’s offered as an individualized decision for men roughly 55 to 69. Newer multi-cancer blood tests exist but remain unproven for reducing deaths and are not yet recommended by guideline bodies.

References

• CDC — Screening for Breast Cancer
• CDC — Screening for Colorectal Cancer
• NHS — Cervical Screening

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.